دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 30,000,000 تومان- قیمت ویژه : 6,250,000تومان
دسترسی یکماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 31 ﺭﻭﺯ
قیمت : 3,000,000 تومان- قیمت ویژه : 1,250,000تومان
About the cover image
doi : 10.1016/S0360-3016(25)06444-2
Volume 124, Issue 1, 1 January 2026, Page A8
Issue Highlights
doi : 10.1016/S0360-3016(25)06445-4
Volume 124, Issue 1, 1 January 2026, Pages A9-A11
Empowering Patients Through Knowledge: Transforming Cancer Care With Improved Education
doi : 10.1016/j.ijrobp.2025.11.003
Volume 124, Issue 1, 1 January 2026, Pages 1-6
A Juggling Act: Managing Limited Metastatic Disease in Anal Cancer
doi : 10.1016/j.ijrobp.2025.08.065
Volume 124, Issue 1, 1 January 2026, Pages 7-8
Choosing Wisely: Patient Selection for Local Therapy in Oligometastatic Anal Cancer
doi : 10.1016/j.ijrobp.2025.09.046
Volume 124, Issue 1, 1 January 2026, Page 9
Sequencing the InterAACTion Between Systemic and Local Treatments
doi : 10.1016/j.ijrobp.2025.08.064
Volume 124, Issue 1, 1 January 2026, Pages 9-10
Opening Move: When to Lead With Systemic Therapy in Synchronous Oligometastatic Anal Cancer
doi : 10.1016/j.ijrobp.2025.09.032
Volume 124, Issue 1, 1 January 2026, Pages 10-11
Curative Intent Despite Nodal Dissemination in Anal Cancer
doi : 10.1016/j.ijrobp.2025.08.063
Volume 124, Issue 1, 1 January 2026, Page 11
All Along the Watchtower: Life Lessons in the Quality of Clinical Trials
doi : 10.1016/j.ijrobp.2025.08.007
Volume 124, Issue 1, 1 January 2026, Pages 12-19
Red Journal Reviews: Typology, Methodology, and Standards
doi : 10.1016/j.ijrobp.2025.08.004
Volume 124, Issue 1, 1 January 2026, Pages 20-26
Strengthening Radiation Therapy Access in Latin America Through SOLAR: A Collaborative Future
doi : 10.1016/j.ijrobp.2025.07.1448
Volume 124, Issue 1, 1 January 2026, Pages 27-28
TEMPORARY REMOVAL: The Significance of the P Value
doi : 10.1016/j.ijrobp.2025.07.1436
Volume 124, Issue 1, 1 January 2026, Pages 29-35
A Solution in Search of a Problem: Why the Current Advanced Practice Radiation Therapist Model Doesn’t Fit the United States Health Care Landscape
doi : 10.1016/j.ijrobp.2025.05.080
Volume 124, Issue 1, 1 January 2026, Pages 36-38
Missing the Target: Radiation, “Toxicity,” and Public Fear
doi : 10.1016/j.ijrobp.2025.08.003
Volume 124, Issue 1, 1 January 2026, Pages 39-40
Private Equity Acquisitions in Oncology: Impact on Market Share and Prices
doi : 10.1016/j.ijrobp.2025.07.1444
Volume 124, Issue 1, 1 January 2026, Pages 41-48
Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up of NRG Oncology RTOG 9911
doi : 10.1016/j.ijrobp.2025.07.1434
Volume 124, Issue 1, 1 January 2026, Pages 50-60
Self-Perceived Hearing Outcomes With Radiation and Cisplatin or Radiation and Cetuximab for Patients With Human Papilloma Virus (HPV)-Positive Oropharyngeal Cancer—Results From NRG Oncology RTOG 1016
doi : 10.1016/j.ijrobp.2025.08.021
Volume 124, Issue 1, 1 January 2026, Pages 61-69
The Role of External Beam Radiation Therapy in Thyroid Cancer Management: A Scoping Review
doi : 10.1016/j.ijrobp.2025.09.050
Volume 124, Issue 1, 1 January 2026, Pages 70-91
Elective Neck Irradiation: “Thou Shalt Not Harm!”
doi : 10.1016/j.ijrobp.2025.08.015
Volume 124, Issue 1, 1 January 2026, Pages 92-95
Read Between the (Isodose) Lines
doi : 10.1016/j.ijrobp.2025.08.016
Volume 124, Issue 1, 1 January 2026, Pages 96-97
Postoperative Adjuvant Treatments for Cervical Cancer: A Network Meta-Analysis
doi : 10.1016/j.ijrobp.2025.07.1440
Volume 124, Issue 1, 1 January 2026, Pages 98-108
Late Toxicities and Quality of Life After a Radiation Boost for Breast Ductal Carcinoma In Situ: Boost or No Boost in DCIS Randomized Trial
doi : 10.1016/j.ijrobp.2025.07.1442
Volume 124, Issue 1, 1 January 2026, Pages 109-121
Preoperative Radiation Therapy-Induced Molecular and Immune Modulation in Early-Stage Breast Cancer: Results From the YOUNGSTER trial
doi : 10.1016/j.ijrobp.2025.07.1443
Volume 124, Issue 1, 1 January 2026, Pages 122-132
HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-Risk Patients With Breast Cancer (HYPART): Acute Toxicity Results
doi : 10.1016/j.ijrobp.2025.07.1447
Volume 124, Issue 1, 1 January 2026, Pages 133-146
Grid Spatially Fractionated Radiation Therapy for Bulky Tumors: A Large Single Institution Experience
doi : 10.1016/j.ijrobp.2025.08.013
Volume 124, Issue 1, 1 January 2026, Pages 147-158
Publication Disparity in Lymphomatous Hematologic Radiation Oncology
doi : 10.1016/j.ijrobp.2025.08.018
Volume 124, Issue 1, 1 January 2026, Pages 159-163
Low-dose Radiation Therapy Concurrent With Atezolizumab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: 3-Year Follow-up of a Multicenter, Single-arm, Phase 2 Trial (MATCH)
doi : 10.1016/j.ijrobp.2025.06.3872
Volume 124, Issue 1, 1 January 2026, Pages 164-173
A Potential Path Toward Finally Improving Outcomes With Concurrent Immunotherapy and Chemoradiation for Lung Cancer: Low-Dose Radiation Therapy Lessons From the MATCH Trial in Extensive-Stage Small Cell Lung Cancer
doi : 10.1016/j.ijrobp.2025.09.014
Volume 124, Issue 1, 1 January 2026, Pages 174-176
Evaluating the Immune Response After Targeted Radionuclide Therapy: Toward a Correlation Between Absorbed Dose and Response
doi : 10.1016/j.ijrobp.2025.06.3855
Volume 124, Issue 1, 1 January 2026, Pages 177-189
Radiation-Induced Loss of Tumor-Reactive T Cells Calls for More Rationally Designed Radioimmunotherapy Approaches
doi : 10.1016/j.ijrobp.2025.08.020
Volume 124, Issue 1, 1 January 2026, Pages 190-193
Predicting Radiation Pneumonitis Integrating Clinical Information, Medical Text, and 2.5D Deep Learning Features in Lung Cancer
doi : 10.1016/j.ijrobp.2025.07.1437
Volume 124, Issue 1, 1 January 2026, Pages 194-205
External Validation of Dose Patterns and Dosimetric Predictors for Radiation-Induced Esophagitis In Non-Small Cell Lung Cancer
doi : 10.1016/j.ijrobp.2025.07.1445
Volume 124, Issue 1, 1 January 2026, Pages 206-214
Beyond Technology: The Impact of Personal Physics Consultation on Patient Anxiety in Breast Cancer Radiation Therapy
doi : 10.1016/j.ijrobp.2025.07.1446
Volume 124, Issue 1, 1 January 2026, Pages 215-223
In Regard to Chhabra et al
doi : 10.1016/j.ijrobp.2025.09.008
Volume 124, Issue 1, 1 January 2026, Pages 224-225
In Reply to Harnett
doi : 10.1016/j.ijrobp.2025.09.010
Volume 124, Issue 1, 1 January 2026, Pages 225-226
In Regard to Chhabra et al
doi : 10.1016/j.ijrobp.2025.10.021
Volume 124, Issue 1, 1 January 2026, Pages 226-227
In Reply to Starrs et al
doi : 10.1016/j.ijrobp.2025.10.023
Volume 124, Issue 1, 1 January 2026, Pages 227-228
In Regard to Jainar et al.
doi : 10.1016/j.ijrobp.2025.07.1452
Volume 124, Issue 1, 1 January 2026, Page 228
In Reply to Kao
doi : 10.1016/j.ijrobp.2025.08.005
Volume 124, Issue 1, 1 January 2026, Pages 228-229
In Regard to Hanna et al.
doi : 10.1016/j.ijrobp.2025.08.022
Volume 124, Issue 1, 1 January 2026, Pages 229-230
In Regard to Yilmaz et al.
doi : 10.1016/j.ijrobp.2025.07.1450
Volume 124, Issue 1, 1 January 2026, Pages 230-231
In Reply to Akhtar et al
doi : 10.1016/j.ijrobp.2025.07.1451
Volume 124, Issue 1, 1 January 2026, Pages 231-232
In Regard to Gaeta et al
doi : 10.1016/j.ijrobp.2025.09.003
Volume 124, Issue 1, 1 January 2026, Page 232
In Reply to Meng et al
doi : 10.1016/j.ijrobp.2025.09.005
Volume 124, Issue 1, 1 January 2026, Pages 232-234
